Cargando…
Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
OBJECTIVES: To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. DESIGN: Single-center, retrospective, observational analysis. SET...
Autores principales: | Kovacevic, Mary P., Dube, Kevin M., Lupi, Kenneth E., Szumita, Paul M., DeGrado, Jeremy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808527/ https://www.ncbi.nlm.nih.gov/pubmed/33490957 http://dx.doi.org/10.1097/CCE.0000000000000330 |
Ejemplares similares
-
The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors
por: Corrado, Michael J., et al.
Publicado: (2020) -
Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019
por: DeGrado, Jeremy R., et al.
Publicado: (2020) -
Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
por: Schuler, Brian R., et al.
Publicado: (2020) -
Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults
por: Hamidi, Arzo, et al.
Publicado: (2021) -
Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
por: Khan, Sikandar H., et al.
Publicado: (2020)